Fig. 3.
(A) Distribution of axon profile lengths in systemic BDNF knockout mice (Tam-Cre::BDNFf/f) whose cut nerves had been repaired with a nerve graft from a systemic BDNF knockout mouse and left untreated, were treated topically with 7,8 DHF, or were treated topically with deoxygedunin. (B) Average median axon profile lengths (+SEM) for the four groups shown in A. (C) Average (+SEM) percentage of axon profiles that had elongated at least 1.5 mm during the 2-wk survival period in the four groups of mice in A.